Verona Pharma Plc Operating Income

Verona Pharma Plc (VRNA) currently reports a operating income of $-56M as of June 2025. That compares with $-130M in the prior-year period — up 57.9% year over year. Use the charts on this page to explore Verona Pharma Plc's operating income history and peer comparisons.

Verona Pharma Plc's operating income increased from $-130M to $-56M — a 57.9% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Verona Pharma Plc reported $-56M in operating income as of June 2025. That compares with $-130M in the prior-year period — up 57.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Verona Pharma Plc, and consider following VRNA for alerts when major investors trade the stock.

Verona Pharma Plc is classified in the Healthcare sector. On operating income, it currently shows $-56M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VRNA with unrelated industries.